Drug-induced QT interval prolongation and major adverse cardiac events: Meta-analysis of randomized controlled trials
MacSphere (McMaster University) · 2023-10-01
DOI: 10.71548/3286 ↗At a glance
Metaanalyse in MacSphere (McMaster University), published on 2023-10-01. Written by Garcia and 19 co-authors.
Abstract (original language)
Background
QT-prolonging medications (QTPMeds) have become a major source of clinical concern regarding medication-related major adverse cardiac events (MACE); MACE events are rare and it is not clear if all QTPMeds create harm, or in which circumstances.
Objectives
Systematically review the study data on the association between QTPMedsand MACE; here we report on a subset of randomized trials.
Discussion
Most trials are not statistically powered to detect MACE
Subjects
Cite
APA
Garcia, M, Tsang, J, Lohit, S, Deng, F, Chang, O, Cairns, K, Rehman, N, Hijazi, W, Mbuagbaw, L, Holbrook, & AM (2023). Drug-induced QT interval prolongation and major adverse cardiac events: Meta-analysis of randomized controlled trials. MacSphere (McMaster University). https://doi.org/10.71548/3286
Vancouver
Garcia, M, Tsang, J, Lohit, S, et al. Drug-induced QT interval prolongation and major adverse cardiac events: Meta-analysis of randomized controlled trials. MacSphere (McMaster University). 2023. doi:10.71548/3286
BibTeX
@article{Garcia2023,
author = {Garcia and M and Tsang and J and Lohit and S and Deng and F and Chang and O and Cairns and K and Rehman and N and Hijazi and W and Mbuagbaw and L and Holbrook and AM},
title = {Drug-induced QT interval prolongation and major adverse cardiac events: Meta-analysis of randomized controlled trials},
journal = {MacSphere (McMaster University)},
year = {2023},
doi = {10.71548/3286}
}
EUVIMED